Laura J. Simon, Vernon M. Chinchilli
When conducting a paired 2 × 2 crossover design, each subject is paired with another subject with similar characteristics. The pair is then randomized to the same sequence of two treatments. That is, the two subjects receive the first experimental treatment, and then they cross over and receive the other experimental treatment(s). The paired 2 × 2 crossover design that was used in the Beta Adrenergic Response by GEnotype (BARGE) Study conducted by the National Heart, Lung and Blood Institute’s Asthma Clinical Research Network (ACRN) has been described elsewhere. When the data arising from such a design are balanced and complete – or if at least any missingness that occurs is at random – general linear mixed-effects model methods can be used to analyze the data. In this paper, we present a method based on a pattern-mixture model for analyzing the data arising from a paired 2 × 2 crossover design when some of the data are missing in a non-ignorable fashion. Because of its inherent scientific interest, we focus our particular attention on the estimation of the treatment-by-type of subject interaction term. Finally, we illustrate the pattern-mixture model methods described in this paper on the data arising from the BARGE study.
References
[1] Cochran, W. G. (1983). Planning and Analysis of Observational Studies. Wiley, New York.
Mathematical Reviews (MathSciNet):
MR720048
[2] Jones, B. and Kenward, M. G. (1989). Design and Analysis of Cross-over Trials. Chapman and Hall/CRC Press, Boca Raton, FL.
[3] Ratkowsky, D. A., Evans, M. A. and Alldredge, J. R. (1993). Cross-Over Experiments. Dekker, New York.
[4] Senn, S. (2002). Cross-over Trials in Clinical Research, 2nd ed. Wiley, New York.
[5] Kephart, D. K., Chinchilli, V. M., Hurd, S. and Cherniack, R. for the Asthma Clinical Research Network. (2001). The organization of the Asthma Clinical Research Network: A multicenter, multiprotocol clinical trials team. Control. Clin. Trials 22(Suppl) 119S–125S.
[6] Israel, I., Chinchilli, V. M., Ford, J. G., et al. for the National Heart, Lung, and Blood Insitute’s Asthma Clinical Research Network. (2004). Use of regularly scheduled albuterol treatment in asthma: Genotype-stratified, randomized, placebo-controlled cross-over trial. Lancet 364 1505–1512.
[7] Little, R. J. A. (1995). Modeling the drop-out mechanism in repeated-measures studies. J. Amer. Statistic. Assoc. 90 1112–1121.
[8] Rubin, D. B. (1976). Inference and missing data. Biometrika 63 581–592.
Mathematical Reviews (MathSciNet):
MR455196
[9] Little, R. J. A. and Rubin, D. B. (2002). Statistical Analysis with Missing Data. Wiley, New York.
[10] Simon, L. J. and Chinchilli, V. M. (2007). A matched crossover design for clinical trials. Contemp. Clin. Trials 28 638–646.
[11] Laird, N. M. and Ware, J. H. (1982). Random effects models for longitudinal data: an overview of recent results. Biometrics 38 963–974.
[12] Ekbohm, G. and Melander, H. (1989). The subject-by-formulation interaction as a criterion for interchangeability of drugs. Biometrics 45 1249–1254.
[13] Sheiner, L. B. (1992). Bioequivalence revisited. Statistics in Medicine 11 1777–1788.
[14] Chinchilli, V. M. and Esinhart, J. D. (1996). Design and analysis of intra-subject variability in cross-over experiments. Statistics in Medicine 15 1619–1634.
[15] Putt, M. and Chinchilli, V. M. (1999). A mixed-effects model for the analysis of repeated measures cross-over studies. Statistics in Medicine 18 3037–3058.
[16] Schafer, J. L. (1997). Analysis of Incomplete Multivariate Data. Chapman and Hall/CRC Press, Boca Raton, FL.
